← Leaderboards
Joy Melnikow
University Of California Davis
$3,604,743
Attributed
$3,604,743
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $460.8K · FY2005–18$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
AHRQ$2,060,113 · 1
NIH$1,394,630 · 2
CDC$150,000 · 1
By mechanism
T32$2,060,113 · 1
R01$1,394,630 · 2
U58$150,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Davis
Same institution · by research overlap
- Hongzhe Lee$15,692,515
- Michael F. Seldin$5,122,317
- Raymond L Rodriguez$0
- Fernando E. Viteri$812,520
Others in their field
Top investigators on “Cost Effectiveness”
- Lawrence Corey · Fred Hutchinson Cancer Center$305,188,797
- David R. Weir · University Of Michigan At Ann Arbor$265,604,440
- Jeffrey P Krischer · University Of South Florida$257,227,881
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Everette D Joseph · Howard University$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
Research focus
Cost EffectivenessPreferenceClinical ResearchBreast NeoplasmsFemaleBehavioral /Social Science Research TagHuman SubjectTamoxifenChemopreventionCancer PreventionWomen'S HealthCodeCervicalCohortDeveloping CountriesClassificationBaseData SetCytologyCost Effectiveness AnalysisCessation Of LifeDeveloped CountriesCostCervical Intraepithelial Neoplasia
Grant awards (16)
Quality Safety Comparative Effectiveness Research Training (QSCERT)$164,411
T32 · FY2018 · HS · contact PI
Quality Safety Comparative Effectiveness Research Training (QSCERT)$421,896
T32 · FY2017 · HS · contact PI
Quality Safety Comparative Effectiveness Research Training (QSCERT)$5,357
T32 · FY2017 · HS · contact PI
Quality Safety Comparative Effectiveness Research Training (QSCERT)$460,780
T32 · FY2016 · HS · contact PI
Quality Safety Comparative Effectiveness Research Training (QSCERT)$398,413
T32 · FY2015 · HS · contact PI
Quality Safety Comparative Effectiveness Research Training (QSCERT)$389,664
T32 · FY2014 · HS · contact PI
Quality Safety Comparative Effectiveness Research Training (QSCERT)$219,592
T32 · FY2013 · HS · contact PI
CD11-1102, Promoting Health Policy and Disease Prevention$150,000
U58 · FY2011 · CD · contact PI
Surveillance Strategies Following Treatment for CIN$139,162
R01 · FY2007 · CA · contact PI
Surveillance Strategies Following Treatment for CIN$342,172
R01 · FY2006 · CA · contact PI
Surveillance Strategies Following Treatment for CIN$296,749
R01 · FY2005 · CA
TAMOXIFEN &BREAST CANCER--ACCEPTANCE/COST EFFECTIVENESS$267,075
R01 · FY2002 · CA
TAMOXIFEN &BREAST CANCER--ACCEPTANCE/COST EFFECTIVENESS$18,018
R01 · FY2002 · CA
TAMOXIFEN &BREAST CANCER--ACCEPTANCE/COST EFFECTIVENESS$171,143
R01 · FY2001 · CA
TAMOXIFEN &BREAST CANCER--ACCEPTANCE/COST EFFECTIVENESS$20,938
R01 · FY2001 · CA
TAMOXIFEN &BREAST CANCER--ACCEPTANCE/COST EFFECTIVENESS$139,373
R01 · FY2000 · CA